Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

BACKGROUND: Prostate cancer screening depends on a careful balance of benefits, in terms of reduced prostate cancer mortality, and harms, in terms of overdiagnosis and overtreatment. We aimed to estimate the effect on overdiagnosis of restricting prostate specific antigen (PSA) testing by age and ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Vickers, Andrew J, Sjoberg, Daniel D, Ulmert, David, Vertosick, Emily, Roobol, Monique J, Thompson, Ian, Heijnsdijk, Eveline AM, De Koning, Harry, Atoria-Swartz, Coral, Scardino, Peter T, Lilja, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922189/
https://www.ncbi.nlm.nih.gov/pubmed/24512643
http://dx.doi.org/10.1186/1741-7015-12-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922189/
https://www.ncbi.nlm.nih.gov/pubmed/24512643
http://dx.doi.org/10.1186/1741-7015-12-26

Ejemplares similares